FOSTER CITY, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced financial results for the...
News
Vaxcyte to Report Fourth Quarter and Full Year 2020 Financial Results on March 29, 2021
FOSTER CITY, Calif., March 22, 2021 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common an… […]
News
CORRECTION – Vaxcyte Reports Second Quarter 2020 Financial Results and Provides Business Update
FOSTER CITY, Calif., Aug. 12, 2020 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Vaxcyte, Inc. (Nasdaq: PCVX), please note that in the first bullet under “Recent Highlights”, the date should be June 16, 2020, not Ju… […]
News
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
FOSTER CITY, Calif., June 16, 2020 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and… […]
